Aucken H M, O'Neill G, Ganner M, Dinerstein N, Ali M, Murchan S
Laboratory of Healthcare-Associated Infection, Specialist and Reference Microbiology Division, Health Protection Agency, London, UK.
J Hosp Infect. 2006 Jun;63(2):170-8. doi: 10.1016/j.jhin.2005.12.012. Epub 2006 Apr 24.
Since 1998, an increasing number of meticillin-resistant Staphylococcus aureus (MRSA) isolates with one of two characteristic phage patterns have been referred to the authors' laboratory from Northern Ireland. These strains were designated 'Irish-1' and 'Irish-2'. Analysis of 956 submitted isolates classified as Irish-1 or Irish-2 showed that 97% of the former and 95% of the latter were from Northern Ireland. Only 0.2% and 3%, respectively, were from England. Eleven Irish-2 isolates had been referred from Western Australia as representatives of an epidemic strain originally isolated there in 1994. Ninety isolates with the Irish-1 phage pattern and 91 isolates with the Irish-2 phage pattern, from numerous hospitals, were characterized by SmaI pulsed-field gel electrophoresis (PFGE), toxin gene carriage and antibiotic susceptibility. PFGE showed that, within each collection, a few isolates represented unrelated strains, but the majority were within six band differences of the most common profiles. Half of the Irish-1 isolates were homogeneous, with 22 DNA profiles among the remainder. Irish-2 isolates had two common profiles, D1 and D2, equally divided between one-third of the isolates and differing from each other by two bands; the remaining isolates shared 31 DNA profiles. Cluster analysis showed some overlap in DNA profiles between the Irish-1 and Irish-2 strains, but clear separation from other epidemic MRSA strains. There was no obvious correlation between PFGE profile and either antibiotic resistance pattern or toxin gene possession. All but three Irish-1 isolates possessed only the staphylococcal enterotoxin A (sea) gene, whereas almost all Irish-2 isolates were negative for all 12 enterotoxin genes. Sixty-nine percent of Irish-2 isolates were resistant to ciprofloxacin, erythromycin, kanamycin, neomycin and streptomycin, while 90% of Irish-1 isolates were resistant to all these plus gentamicin and mupirocin. All isolates were sensitive to quinupristin/dalfopristin, teicoplanin and vancomycin. Urease production was negative in both strains. The results suggest that Irish-1 and Irish-2 are distinct epidemic strains, identifiable by phage typing, DNA profiles, antibiotic resistance and toxin gene carriage.
自1998年以来,越来越多具有两种特征性噬菌体模式之一的耐甲氧西林金黄色葡萄球菌(MRSA)分离株从北爱尔兰被送至作者所在实验室。这些菌株被命名为“爱尔兰-1”和“爱尔兰-2”。对956株提交的分类为爱尔兰-1或爱尔兰-2的分离株进行分析发现,前者97%、后者95%来自北爱尔兰。分别仅有0.2%和3%来自英格兰。11株爱尔兰-2分离株从西澳大利亚被送来,作为1994年在该地最初分离出的一种流行菌株的代表。对来自众多医院的90株具有爱尔兰-1噬菌体模式的分离株和91株具有爱尔兰-2噬菌体模式的分离株进行了SmaI脉冲场凝胶电泳(PFGE)、毒素基因携带情况及抗生素敏感性分析。PFGE显示,在每个收集的样本中,少数分离株代表不相关的菌株,但大多数与最常见图谱的条带差异在6条以内。一半的爱尔兰-1分离株是同源的,其余分离株有22种DNA图谱。爱尔兰-2分离株有两种常见图谱,即D1和D2,各占三分之一的分离株,两者相差2条带;其余分离株共有31种DNA图谱。聚类分析显示爱尔兰-1和爱尔兰-2菌株的DNA图谱有一些重叠,但与其他流行的MRSA菌株明显分开。PFGE图谱与抗生素耐药模式或毒素基因携带情况之间没有明显相关性。除3株爱尔兰-1分离株外,所有分离株仅携带葡萄球菌肠毒素A(sea)基因,而几乎所有爱尔兰-2分离株对所有12种肠毒素基因均呈阴性。69%的爱尔兰-2分离株对环丙沙星、红霉素、卡那霉素、新霉素和链霉素耐药,而90%的爱尔兰-1分离株对所有这些抗生素以及庆大霉素和莫匹罗星耐药。所有分离株对奎奴普丁/达福普汀、替考拉宁和万古霉素敏感。两种菌株的脲酶产生均为阴性。结果表明,爱尔兰-1和爱尔兰-2是不同的流行菌株,可通过噬菌体分型、DNA图谱、抗生素耐药性和毒素基因携带情况来鉴别。